Home Site Index Contact Us
  Fri, May 9, 2008 
 
 
 
Latest News
ImClone Systems Reports First Quarter 2008 Financial Results
>>more

ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
>>more

 
 
Click here to learn more about Erbitux ImClone Systems Incorporated is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.


Featured Events

May 15 - 18
SCIENTIFIC CONFERENCE:
ONS Annual Meeting
Philadelphia, PA

>>more
May 30 - June 3
SCIENTIFIC CONFERENCE:
ASCO Annual Meeting
Chicago, IL

>>more
Company Overview | Clinical Programs | Research | News | Investor Relations | Calendar | Careers | Product Support Program  
© 2008 ImClone Systems Incorporated